S 3502 New Jersey Senate · 2026-2027 Regular Session

Requires health insurance and Medicaid coverage for treatment of stuttering.*

S 3502 requires all health insurance plans and Medicaid in New Jersey to cover stuttering treatment, including both habilitative (helping learn or maintain speech skills) and rehabilitative (restoring lost speech skills) speech therapy. It mandates coverage for in-person and telehealth services without cost-sharing like deductibles, copays, or annual limits, and eliminates prior authorization requirements. This directly affects all New Jersey residents with health insurance or Medicaid who need speech therapy for stuttering. The bill applies to all relevant insurance contracts issued in the state, ensuring consistent coverage for medically necessary stuttering treatment.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 12, 2026 Last action May 18, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Reprint · 6 edits
MODERATE
The First Reprint of S3502 makes significant changes to New Jersey's stuttering treatment coverage bill. It removes two key consumer protections (the ban on prior authorization and the ban on cost-sharing) while expanding who can certify treatment necessity and adding 'neurogenic or developmental' as an alternative basis for coverage. The net effect is a trade-off: slightly broader eligibility but weaker safeguards against insurer restrictions on access and out-of-pocket costs.
REQUIREMENT

The requirement that benefits be provided without prior authorization or other utilization management requirements was deleted from every section of the bill (hospital service corporations, medical service corporations, health service corporations, individual policies, group policies, HMOs, small employer plans, State Health Benefits Program, School Employees' program, and Medicaid). Insurers can now impose prior authorization and utilization management on stuttering treatment.

The prohibition on deductibles, coinsurance, copayments, annual benefit limits, and other cost-sharing was deleted from every section of the bill. Patients may now face out-of-pocket costs for stuttering treatment that would not apply to other covered services.

ELIGIBILITY

The medical necessity standard was expanded. Originally, treatment had to be 'determined medically necessary by the subscriber's medical doctor.' Now it can be 'determined to be medically necessary or neurogenic or developmental by the subscriber's medical doctor or licensed speech-language pathologist.' This broadens both the qualifying conditions and who can make the determination.

DEFINITION

A new definition of 'speech-language pathologist' was added in every section, incorporating by reference the definition in section 2 of P.L.1983, c.420 (C.45:3B-2).

SCOPE

Senator Robert W. Singer (District 30) was added as a sponsor and Senators Bramnick and Lagana were added as co-sponsors, indicating broader legislative support.

TECHNICAL

The explanatory statement at the end of the bill was removed in the reprint version.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
May 18, 2026
Committee
Referred to Senate Budget and Appropriations Committee
upper
Feb 12, 2026
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
2 primary · 2 co-sponsors

Sponsors